arrow
K

Koen Van Laere

leuven brain institute
H指数:76
被引数:2.2万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Multimodal Retinal Imaging for the Detection of Early Alzheimer’s Disease: Combining Biochemical, Structural, and Vascular Biomarkers

多模态视网膜成像用于早期阿尔茨海默病的检测:结合生化、结构和血管生物标志物

2026-09-080
OA
The clinical Alzheimer's disease spectrum classified in the A/T/N framework with 18F-Flutemetamol-Centiloid, 18F-MK-6240-CenTauR, and 18F-FDG-AD metaROI: a multicenter memory clinic observational study

以18F-Flutemetamol-Centiloid、18F-MK-6240-CenTauR和18F-FDG-AD metaROI为依据,在A/T/N框架下分类的临床阿尔茨海默病谱:一项多中心记忆诊所观察性研究

2026-05-210
OAAI
Anatomy-corrected metabolic asymmetry predicts seizure freedom after surgery in focal cortical dysplasia

解剖学校正的代谢不对称性预测局灶性皮层发育不良术后癫痫发作的控制情况

2026-04-100
OAAI
Meningioma theranostics: a retrospective analysis of somatostatin receptor PET/CT imaging and peptide receptor radionuclide therapy

脑膜瘤诊疗:生长抑素受体PET/CT成像及肽受体放射性核素疗法的回顾性分析

2026-02-170
PRE
cGMP-compliant high-yield automated production of [18F]AlF-FAPI-74: optimization of quality control and evaluation of molar dose impact

cGMP合规的高产率自动化生产[18F]AlF-FAPI-74:质量控制的优化及摩尔剂量影响的评估

2025-12-140
OAAI
[18F]MFBG PET/CT imaging of myocardial sympathetic innervation in healthy controls and patients with parkinson’s disease: dosimetry and pharmacokinetics

[18F]MFBG PET/CT成像在健康对照者和帕金森病患者心肌交感神经支配中的应用:剂量学及药代动力学

2025-09-090
PRE
Dosimetry and kinetic modelling of [18F]JNJ-64511070, a novel PET ligand to quantify AMPA-associated TARP-γ8 receptors in the human brain

剂量测定和动力学建模研究 [18F]JNJ-64511070,一种用于定量人脑中AMPA相关TARP-γ8受体的新型PET配体

2025-07-220
PRE
Loss of the lysosomal lipid flippase ATP10B leads to progressive dopaminergic neurodegeneration and parkinsonian motor deficits

溶酶体脂质 flipping 酶ATP10B的缺失导致进行性多巴胺能神经变性及帕金森样运动缺陷

2025-07-170
OAAI
Tau PET positivity in individuals with and without cognitive impairment varies with age, amyloid-β status, APOE genotype and sex

tau PET阳性率在伴有和不伴有认知障碍的个体中,随年龄、Aβ状态、APOE基因型和性别而变化。

2025-07-160
OA